Literature DB >> 25385558

Pyoderma gangrenosum as a first presentation of inflammatory bowel disease.

Shahana Shahid1, Margaret Myszor1, Aminda De Silva1.   

Abstract

Up to 40% of patients with inflammatory bowel disease (IBD) develop an extraintestinal manifestation of the disease with the skin being the most commonly involved organ. Pyoderma gangrenosum (PG), an autoinflammatory non-infectious neutrophilic dermatosis, occurs in 1-2% of patients with IBD. PG can follow a course independent to that of the bowel disease, however, most reported cases describe PG occurring in patients with an established diagnosis of IBD. We present a case of a young patient who presented with axillary skin ulceration, which was subsequently diagnosed as PG. On further investigation for a possible underlying cause, she was found to have Crohn's disease. She had not developed any preceding change in her bowels and did not have abdominal pain; the IBD was diagnosed on endoscopic findings. This case is also unusual for the distribution of the PG lesions that typically occur in the lower limbs. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25385558      PMCID: PMC4225318          DOI: 10.1136/bcr-2014-204853

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Authors:  Stephan R Vavricka; Lionel Brun; Pierluigi Ballabeni; Valérie Pittet; Bettina Mareike Prinz Vavricka; Jonas Zeitz; Gerhard Rogler; Alain M Schoepfer
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

Review 2.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

Review 3.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 4.  Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.

Authors:  Arthur Barrie; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

Review 5.  Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.

Authors:  Angelo V Marzano; Alessandro Borghi; Antoni Stadnicki; Carlo Crosti; Massimo Cugno
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 6.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

  6 in total
  1 in total

1.  Pyoderma gangrenosum confused with congenital preauricular fistula infection: A case report.

Authors:  Yang Zhao; Rou-Yu Fang; Guo-Dong Feng; Ting-Ting Cui; Zhi-Qiang Gao
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.